Jonathan Burgin

Jonathan Burgin

Chief Executive Officer at
BioCancell Therapeutics, Inc.
65 year
Health Technology
Commercial Services
Technology Services

Profile

Jonathan Burgin's current job is as the Chief Executive Officer at BioCancell Therapeutics, Inc. He previously held positions as the Director-Investor Relations at XTL Biopharmaceuticals Ltd., Independent Director at Cellect Biotechnology Ltd., Chief Financial Officer at RADCOM Ltd., Chief Operating Officer at Anchiano Therapeutics Ltd., and Senior Manager at Kesselman & Kesselman.
Prior to these roles, he was a Member at PricewaterhouseCoopers International Ltd. and Chief Financial Officer at Y.L.R.
Capital Markets Ltd. Mr. Burgin obtained his undergraduate degree and MBA from Tel-Aviv University.

Jonathan Burgin active positions

CompaniesPositionStart
Chief Executive Officer 03/06/2012

Former positions of Jonathan Burgin

CompaniesPositionEnd
ANCHIANO THERAPEUTICS LTD Chief Executive Officer 18/10/2016
RADCOM LTD. Director of Finance/CFO 20/05/2011
XTL BIOPHARMACEUTICALS LTD. Public Communications Contact 31/12/2005
Y.L.R. Capital Markets Ltd.
Director of Finance/CFO 31/12/1998
Corporate Officer/Principal -
See the detail of Jonathan Burgin's experience

Training of Jonathan Burgin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

46

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Technology Services

Health Technology

Health Technology

Commercial Services

Consumer Services

Commercial Services

Health Technology

Y.L.R. Capital Markets Ltd.

Health Technology

  1. Stock Market
  2. Insiders
  3. Jonathan Burgin